cdmo.directory
← Compare landing

Emergent BioSolutions CDMO vs Grifols Partnership

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryEmergent BioSolutions CDMOGrifols Partnership
SummaryLeading public health company specializing in medical countermeasures, commercial products, and strategic manufacturing partnerships for biodefense and public health preparedness.CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.
Services
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Technology Transfer
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Other)
  • Vaccine
  • Small Molecule
  • Biologics (Other)
Development capabilitiesData not yet provided.
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
Locations
  • Headquarters, Gaithersburg, Maryland, United States
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Emergent BioSolutions CDMO alternatives · Grifols Partnership alternatives

Markdown mirror: /compare/emergentbiosolutions/grifols.md